Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia
T. Holler, C. Henzen
Swiss Medical Weekly, 2011
View PDFchevron_right
Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors
Jeroen Schouten
Journal of Antimicrobial Chemotherapy, 2005
View PDFchevron_right
Community-acquired pneumonia (CAP) hospitalizations and deaths: is there a role for quality improvement through inter-hospital comparisons?
Willem Aelvoet
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua, 2015
View PDFchevron_right
Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results
Jon Birger Haug
Antimicrobial resistance and infection control, 2014
View PDFchevron_right
Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia
Peter Speelman
Journal of Antimicrobial Chemotherapy, 2007
View PDFchevron_right
A multicentre cluster-randomized clinical trial to improve antibiotic use and reduce length of stay in hospitals: comparison of three measurement and feedback methods
Erik Wilms
Journal of Antimicrobial Chemotherapy, 2021
View PDFchevron_right
Specific control measures for antibiotic prescription are related to lower consumption in hospitals: results from a French multicentre pilot study
Katiuska Miliani
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study
Francesco Blasi
BMC Pulmonary Medicine, 2014
View PDFchevron_right
The association between adherence to national antibiotic guidelines and mortality, readmission and length of stay in hospital inpatients: results from a Norwegian multicentre, observational cohort study
Hege Blix
Antimicrobial Resistance & Infection Control
View PDFchevron_right
Management of community-acquired pneumonia and secular trends at different hospitals
Amaia Bilbao
Respiratory Medicine, 2005
View PDFchevron_right
Predictors of Timely Antibiotic Administration for Patients Hospitalized With Community-Acquired Pneumonia From the Cluster-Randomized EDCAP Trial
Donald Yealy
The American Journal of the Medical Sciences, 2010
View PDFchevron_right
Rapid Antibiotic Delivery and Appropriate Antibiotic Selection Reduce Length of Hospital Stay of Patients With Community-Acquired Pneumonia
David Battleman
Archives of internal medicine, 2002
View PDFchevron_right
Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
Werner Albrich
BMC Pulmonary Medicine, 2012
View PDFchevron_right
Variations in Antimicrobial Use and Cost in More Than 2,000 Patients with Community-acquired Pneumonia
Christopher Coley
The American Journal of Medicine, 1998
View PDFchevron_right
Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France
P. Parneix
Clinical Microbiology and Infection, 2010
View PDFchevron_right
Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06
M. Cizman
Journal of Antimicrobial Chemotherapy, 2010
View PDFchevron_right
Hospital-reported Data on the Pneumonia Quality Measure “Time to First Antibiotic Dose” Are Not Associated With Inpatient Mortality: Results of a Nationwide Cross-sectional Analysis
Usha Periyanayagam, Emilie Powell
Academic Emergency Medicine, 2011
View PDFchevron_right
Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study
Roland Bingisser
BMC Infectious Diseases, 2007
View PDFchevron_right
Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis
Frank Sullivan
Thorax, 2007
View PDFchevron_right
Duration of Antibiotic Use among Adults with Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States
Sujan Reddy
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017
View PDFchevron_right
Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management
Philip Howard, Dryden Matthew
View PDFchevron_right
Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria
Marion Opatowski
Journal of Infection, 2021
View PDFchevron_right
The Belgian policy of funding antimicrobial stewardship in hospitals and trends of selected quality indicators for antimicrobial use, 1999-2010: a longitudinal study
Robin Bruyndonckx, Dirk Vogelaers
BMJ open, 2015
View PDFchevron_right
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate
maftuchah rochmanti
Journal of Forensic Medicine, 2021
View PDFchevron_right
Antibiotic management and early discharge from hospital: an economic analysis
Matthew Dryden
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right
Impact of an Antimicrobial Stewardship Intervention on Shortening the Duration of Therapy for Community-Acquired Pneumonia
Subramani Kandasamy
Clinical Infectious Diseases, 2012
View PDFchevron_right
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
Thomas Higgins
Journal of Antimicrobial Chemotherapy, 2015
View PDFchevron_right
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001
Michelle Cox
Canadian respiratory journal : journal of the Canadian Thoracic Society, 2005
View PDFchevron_right